Bard moves on $500M stock buyback; Vietnam's CRM market in 'significant' growth;

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> C.R. Bard's ($BCR) board of directors has authorized the repurchase of up to $500 million of the company's common stock, beyond the $88 million remaining under a similar authorization from June 2010. Release

> CardiAQ says a surgeon in Denmark has successfully used its transcatheter mitral valve system to implant a bioprosthetic mitral heart valve in an 86-year-old male suffering from severe mitral regurgitation. Release

> Frost & Sullivan reports that a combination of healthcare reforms and an increase in cardiovascular disease incidents has led to significant growth in the Vietnam CRM market. News

> Integrated Diagnostics launched a new Southern California division, dubbed InDi Imaging, to develop its own PET imaging probes. Story

> Svelte Medical Systems is beginning a post-market registry study in Europe of its Svelte coronary stent integrated delivery system. Release

CRO News

@NesaNFierce: FierceCRO just posted its Top 5 Strategic CRO/Pharma Partnerships list! Check it out and let me know what you think! Special Report | Follow @NesaNFierce

> Eli Lilly bets on insulin research and generics manufacturing in China. Article

> Former Sandia employee faces embezzlement charges after stealing nanotech info. Story

> Devicemakers should rely more upon outsourcing and CROs, study says. More

> Zeincro Group and Trial Masters merge to expand Eastern European reach. Report

Biotech News

@FierceBiotech: Devicemakers should rely more upon outsourcing and CROs, study says. Report | Follow @FierceBiotech

@JohnCFierce: Just heard we sold out on the 330-seat venue for our R&D breakfast in Boston Tuesday. Which is pretty cool. Hope to see you there. | Follow @JohnCFierce

@RyanMFierce: Some lab and IT workers targeted in 400 layoffs at AstraZeneca in Sweden. Item | Follow @RyanMFierce

> Third Rock funds $40M launch of San Francisco blood disease biotech. News

> Novo Nordisk centers juvenile diabetes work at new R&D hub. Story

> Economy blamed for jobs shortfall in Bay State's $1B biotech plan. More

> Bugs living in humans breed biotech startups. Article

Pharma News

@FiercePharma: Big Pharma's Japanese sales gain as U.S., Europe lag. News | Follow @FiercePharma

> Austerity, generics push Lundbeck to cut 600 jobs. More

> Who'll be the biggest drugmaker of them all? Report

> Heart docs skeptical of new-generation clotbusters. Article

Pharma Manufacturing News

@EricPFierce: Filtrona completes its acquisition of Lymtech Scientific. News | Follow @EricPFierce

> Smaller Indian drugmakers need support to improve GMPs. Item

> Cuts in drug manufacturing felt in U.K. industrial output. Article

> Loss for CMO Patheon smaller than expected. Story

> Pakistan's ex-health director has heart attack under questioning. Report

Vaccines News

> GeoVax: Meeting the HIV vaccine challenge. Column

> VaxInnate bird flu shot flies into Phase I. More

> Novartis, Cytos Alzheimer's vax shows immune response. Item

> New HPV vax could treat cancer rather than prevent it. News

And Finally... The use of CT and PET scans and other medical imaging technologies is actually on the decline, based on recent independent analyses of Medicare and private insurance data, according to the Medical Imaging & Technology Alliance. MITA issued its statement in response to a recent JAMA study that asserted usage is climbing, increasing radiation exposure risks. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.